From where I stand, the linked article below looks like an opportunistic partisan move. In my view, people from both sides of the dispute (#MAPS AND #Psymposia) managed to slow down the progress of #psychedelicMedicine (maybe for good).
But I agree with Ms. Devenot that, specially by tagging #Left on the title, it is a "transparently partisan attack" that "politicized whistleblowers to appeal to the #Trump administration on behalf of a #pharmaceuticalcompany." (#Lykos)

https://www.nytimes.com/2025/02/04/health/fda-mdma-psychedelic-therapy-psymposia.html?unlocked_article_code=1.vE4.fOfO.GlkdCIj0dlvk&smid=nytcore-ios-share&referringSource=articleShare